Profile
Andrew Metters is Chief Technology Officer of Selah Technologies LLC.
He joined the Company in January, 2007.
Dr. Metters served as an Assistant Professor at Clemson University.
Previously, he held various positions at 3M Co. He has more than 10 years of experience in both industrial and academic environments.
Dr. Metters received a PhD in Chemical Engineering from the Chemical and Biological Engineering Department at the University of Colorado.
Former positions of Andrew Metters
| Companies | Position | End |
|---|---|---|
Selah Technologies LLC
 Selah Technologies LLC Pharmaceuticals: MajorHealth Technology Selah Technologies, LLC is an advanced materials manufacturing company developing and commercializing two proprietary nano technologies. Selah Dots are patent-pending photo luminescent carbon-based nano particles. Selah Tubes™ are enriched single-walled nanotubes with precisely engineered electronic properties protected under U.S. Patent No. 7,374,685. Its growth strategy is to leverage relationships with market leading companies to establish mutually beneficial joint research and development agreements. The company strategy is founded in the conviction that early successes in its target markets will occur via exploitation of nanomaterials in established applications in which their incorporation is both useful and compelling, and addresses needs that nanotechnology can fulfill either immediately or in the very short term. | Chief Tech/Sci/R&D Officer | 2013-04-17 |
| 3M COMPANY | Corporate Officer/Principal | - |
| Clemson University | Corporate Officer/Principal | - |
Training of Andrew Metters
| The University of Colorado | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| 3M COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Selah Technologies LLC
Selah Technologies LLC Pharmaceuticals: MajorHealth Technology Selah Technologies, LLC is an advanced materials manufacturing company developing and commercializing two proprietary nano technologies. Selah Dots are patent-pending photo luminescent carbon-based nano particles. Selah Tubes™ are enriched single-walled nanotubes with precisely engineered electronic properties protected under U.S. Patent No. 7,374,685. Its growth strategy is to leverage relationships with market leading companies to establish mutually beneficial joint research and development agreements. The company strategy is founded in the conviction that early successes in its target markets will occur via exploitation of nanomaterials in established applications in which their incorporation is both useful and compelling, and addresses needs that nanotechnology can fulfill either immediately or in the very short term. | Health Technology |
- Stock Market
- Insiders
- Andrew Metters
